Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Distillery Therapeutics

ANGPTL4 for sepsis-induced endothelial dysfunction

September 6, 2024 6:20 AM UTC

The glycoprotein ANGPTL4 could help treat sepsis-induced endothelial dysfunction by interacting via its N-terminus with the heparan sulfate proteoglycan SDC4 in microvessel endothelial cells, which promotes endothelial cell integrity.

In primary human endothelial cells exposed to Neisseria meningitidis, a bacteria that causes sepsis and meningitis, endothelial cell integrity was higher, and apoptosis was lower when cells were isolated from brain parenchymal microvessels than when they were isolated from derma microvessels. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article